HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms.

AuthorsEmiliano Fabiani, Giulia Falconi, Luana Fianchi, Marianna Criscuolo, Giuseppe Leone, Maria Teresa Voso
JournalHaematologica (Haematologica) Vol. 99 Issue 9 Pg. e152-3 (Sep 2014) ISSN: 1592-8721 [Electronic] Italy
PMID24907359 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Carrier Proteins
  • Nuclear Proteins
  • SETBP1 protein, human
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents (adverse effects)
  • Carrier Proteins (genetics)
  • Female
  • Gamma Rays (adverse effects)
  • Humans
  • Leukemia, Myeloid, Acute (chemically induced, genetics, pathology)
  • Male
  • Middle Aged
  • Mutation
  • Myelodysplastic Syndromes (chemically induced, genetics, pathology)
  • Neoplasms (drug therapy, genetics, pathology, radiotherapy)
  • Nuclear Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: